C.T. Fitzpatrick
Vulcan Value Partners
Vulcan Value Partners Portfolio 13F
Vulcan Value Partners Holdings Activity
- Portfolio value:
- $11.22B≈ (-$362M≈)
- Previous value:
- $11.58B≈
- # of changes:
- 57
- New positions:
- 2
- Reported for:
- 30 Jun 2017 (Q2)
- Latest filing date:
- 14 Aug 2017
Vulcan Value Partners has disclosed a total of 57 changes to the portfolio in the (2017 Q2) SEC report(s): increased the number of shares of 13, bought 2 totally new, decreased the number of shares of 36 and completely sold out 6 position(s).
What stocks did Vulcan Value Partners buy in 2017 Q2?
During 2017 Q2 Vulcan Value Partners has bought 15 securities out of which top 5 purchases (by % change to portfolio) were (CVS) CVS Health Corp (added shares +1.36%), (NOV) NOV Inc (added shares +5.68%), (V) Visa Inc, CL-A (added shares +12.61%), (MA) Mastercard Inc (added shares +5.26%) and (AXS) AXIS CAPITAL HOLDINGS LTD (added shares +2.20%).
In the 2017 Q2 report(s) the following changes have been made to the top investments: (ORCL) Oracle Corp (reduced shares -3.00%), (CVS) CVS Health Corp (added shares +1.36%), (NOV) NOV Inc (added shares +5.68%), (MCK) McKesson Corp (reduced shares -3.93%) and (V) Visa Inc, CL-A (added shares +12.61%).
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
* Current price: this can be a delayed price and may not reflect the real-time market value, however it is too close.
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* Held since / Held for: calculated since the latest "new buy" position. If the security was previously exited and re-entered, only the most recent holding period is counted.